Current role
Charles T. Garner
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Charles T. Garner
The proxy statement of Rein Therapeutics, Inc. reports total compensation of $475,961 for Charles T. Garner in fiscal 2024, including a base salary of $168,750. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Rein Therapeutics, Inc. (RNTX)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rein Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Windsor CEO, COO, Board Member
- Brian Windsor, Ph.D. CEO, COO, Board Member
- Josef H. von Rickenbach Chairman, Board Member
- Charles Garner CFO
- Donald V. Dougherty CFO
- Timothy M. Cunningham CFO
- Manuel Aivado Chief Accounting Officer
- Alan A. Musso Board Member
- Manuel C. Alves-Aivado, M.D., Ph.D. Board Member
- Reinhard Ambros, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Rein Therapeutics, Inc. (RNTX) | Former principal financial officer and principal accounting officer | $168,750 | $475,961 |
| 2023 | Rein Therapeutics, Inc. (RNTX) | Former principal financial officer and principal accounting officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.